Hiroki Ishikawa
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 23, 2025
Construction and Evaluation of a HCoV-OC43 S2 Subunit Vaccine Fused with Nasal Immuno-Inducible Sequence Against Coronavirus Infection.Hiraku Sasaki, Hiroki Ishikawa, Ayako Shigenaga
|Jul 02, 2025
NKT cell deficiency exacerbates adenine-induced renal fibrosis through enhanced Treg infiltration and TGF-β expression.Yoshihiro Kuno, Hiroki Ishikawa, Ryuichi Nagashima
|Dec 17, 2024
Intranasal Immunization with Nasal Immuno-Inducible Sequence-Fused Antigens Elicits Antigen-Specific Antibody Production.Hiraku Sasaki, Yoshio Suzuki, Kodai Morimoto
|Mar 24, 2024
In vitro investigation of the effects of Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 exopolysaccharides on tight junction damage caused by influenza virus infection.Hiroki Ishikawa, Yoshihiro Kuno, Takehiro Yokoo
|Sep 25, 2023
Effects of NKT Cells on Metabolic Disorders Caused by High-Fat Diet Using CD1d-Knockout Mice.Hiroki Ishikawa, Ryuichi Nagashima, Yoshihiro Kuno
|Jan 12, 2022
Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 prevent influenza virus infection and attenuate secondary bacterial infection risk.H Ishikawa, Y Kuno, C Kohda
Pageof 1
